Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen

Simona Di Giambenedetto, Massimiliano Fabbiani, Annalisa Mondi, Barbara Rossetti, Andrea De Luca, M. Zaccarelli, A. Latini, G. Sterrantino, G. D'Ettorre, P. Grima, B. Rossetti, B. Borchi, M. Giuliani, A. Antinori

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Despite not being approved in Europe as first-line therapy, the efavirenz (EFV)-containing single tablet regimen (STR) is frequently used in clinical practice in naïve patients but few data are available on this strategy. In our study, we aimed to assess the risk of EFV discontinuation in patients starting antiretroviral therapy with STR vs. nonSTR.
Original languageEnglish
Pages (from-to)N/A-N/A
JournalHIV Medicine
DOIs
Publication statusPublished - 2015

Keywords

  • STR
  • adherence
  • cART
  • combination antiretroviral therapy
  • toxicity

Fingerprint Dive into the research topics of 'Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen'. Together they form a unique fingerprint.

Cite this